FindTrial
Sign In

18F-Choline PET/MR imaging of recurrent hepatocellular carcinoma

18F-Choline PET/MR imaging of recurrent hepatocellular carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065757
Enrollment
Unknown
Registered
2022-11-14
Start date
2022-11-20
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma (HCC)

Interventions

Gold Standard:Post-operative pathology or follow-up results
Index test:Dual-tracer PET with 18F-FDG and 18F-Choline

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adult patients with recurrent hepatocellular carcinoma diagnosed by West China Hospital of Sichuan University; 2. Self-condition can tolerate 2 PET tests.

Exclusion criteria

Exclusion criteria: 1. History of other tumors; 2. Claustrophobic; 3. Blood glucose level > 8.1mmol/L.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;Accuracy;—

Countries

China

Contacts

Public ContactSu Minggang

West China Hospital, Sichuan University

suminggang@sina.com+86 18980606733

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026